Literature DB >> 10791624

Different articular outcomes of Still's disease in Chinese children and adults.

S J Lin1, H C Chao, D C Yan.   

Abstract

The clinical manifestations, treatment and course, and articular outcomes of 24 children with juvenile-onset Still's disease (JOSD) and 21 adults with adult-onset Still's disease (AOSD) were compared retrospectively. There was no significant difference in the initial clinical and laboratory manifestations except that more adults presented with a sore throat (81% vs. 46%, p = 0.03). Although serum ferritin was almost always elevated in both diseases, adults had significantly higher serum ferritin concentrations compared with those of children. Steroid treatment was required in 71% of children and 52% of adults, while disease-modifying antirheumatic drugs were used in 42% of children and 24% of adults during the course. Chronic arthritis (>6 months) occurred in comparable proportions of patients with JOSD and AOSD (46% vs 38%, p = 0.82), irrespective of the disease pattern (monocyclic or polycyclic). However, severe deforming arthritis with marked functional limitation occurred only in JOSD, particularly with polyarthritis at disease onset (more than five affected joints). In contrast, AOSD patients with chronic arthritis had a favourable functional outcome at the end of the follow-up. Our study suggested different articular outcomes of Still's disease in Chinese children and adults.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10791624     DOI: 10.1007/s100670050030

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  9 in total

1.  A multicenter study of patients with adult-onset Still's disease compared with systemic juvenile idiopathic arthritis.

Authors:  Salih Pay; Nuran Türkçapar; Mukaddes Kalyoncu; Ismail Simşek; Esin Beyan; Ihsan Ertenli; M Akif Oztürk; Nurşen Düzgün; Hakan Erdem; Zeynep Ozbalkan; Sedat Kiraz; Gülay Kinikli; Nesrin Besbas; Ayhan Dinç; Aşkin Ateş; Umit Olmez; Meral Calgüneri; Olcay Tiryaki Aydintuğ; Ayşin Bakkaloğlu; Mustafa Turan; Murat Turgay; Yaşar Karaaslan; Rezzan Topaloğlu; Murat Duman; Seza Ozen
Journal:  Clin Rheumatol       Date:  2005-12-20       Impact factor: 2.980

Review 2.  Biomarkers in systemic juvenile idiopathic arthritis: a comparison with biomarkers in cryopyrin-associated periodic syndromes.

Authors:  Nanguneri Nirmala; Alexei Grom; Hermann Gram
Journal:  Curr Opin Rheumatol       Date:  2014-09       Impact factor: 5.006

Review 3.  Prognostic factors in juvenile idiopathic arthritis.

Authors:  A M Prieur; G Chèdeville
Journal:  Curr Rheumatol Rep       Date:  2001-10       Impact factor: 4.686

4.  Bibliometrics analysis on the research status and trends of adult-onset Still's disease: 1921-2021.

Authors:  Aining Qin; Jing Sun; Chao Gao; Chunying Li
Journal:  Front Immunol       Date:  2022-07-18       Impact factor: 8.786

Review 5.  New insights on multigenic autoinflammatory diseases.

Authors:  Petros Efthimiou; Olga Petryna; Priscila Nakasato; Apostolos Kontzias
Journal:  Ther Adv Musculoskelet Dis       Date:  2022-09-03       Impact factor: 3.625

6.  Application of the Yamaguchi criteria for classification of "suspected" systemic juvenile idiopathic arthritis (sJIA).

Authors:  Sharath Kumar; Divya Shree Kunhiraman; Lalitha Rajam
Journal:  Pediatr Rheumatol Online J       Date:  2012-11-23       Impact factor: 3.054

7.  Application of the international league against rheumatism classification criteria for systemic juvenile idiopathic arthritis as a prognostic factor in patients with adults-onset Still's disease.

Authors:  Ji Won Yang; Eunyoung Lee; Ji-Yeon Seo; Ju-Yang Jung; Chang-Hee Suh; Hyoun-Ah Kim
Journal:  Pediatr Rheumatol Online J       Date:  2018-01-25       Impact factor: 3.054

8.  Genetic Association and Expression Correlation between Colony-Stimulating Factor 1 Gene Encoding M-CSF and Adult-Onset Still's Disease.

Authors:  Yi-Ming Chen; Wei-Ting Hung; Wan-Chun Chang; Chia-Wei Hsieh; Wen-Hung Chung; Joung-Liang Lan; Ning-Rong Gung; Yun-Shien Lee; Der-Yuan Chen; Shuen-Iu Hung
Journal:  J Immunol Res       Date:  2020-02-14       Impact factor: 4.818

9.  Management of adult-onset Still's disease with interleukin-1 inhibitors: evidence- and consensus-based statements by a panel of Italian experts.

Authors:  Serena Colafrancesco; Maria Manara; Alessandra Bortoluzzi; Teodora Serban; Gerolamo Bianchi; Luca Cantarini; Francesco Ciccia; Lorenzo Dagna; Marcello Govoni; Carlomaurizio Montecucco; Roberta Priori; Angelo Ravelli; Paolo Sfriso; Luigi Sinigaglia
Journal:  Arthritis Res Ther       Date:  2019-12-11       Impact factor: 5.156

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.